TY - JOUR
T1 - Symptom validity and neuropsychological assessment: A survey of practices and beliefs of neuropsychologists in six european countries
AU - Dandachi-FitzGerald, Brechje
AU - Ponds, Rudolf W. H. M.
AU - Merten, Thomas
PY - 2013/12
Y1 - 2013/12
N2 - During the last decades, symptom validity has become an important topic in the neuropsychological and psychiatric literature with respect to howit relates to malingering, factitious disorder, and somatoform complaints.We conducted a surveyamongneuropsychologists (N = 515) from six European countries (Germany, Italy, Denmark, Finland, Norway, and the Netherlands).We queried the respondents about the tools they used to evaluate symptom credibility in clinical and forensic assessments and other issues related to symptom validity testing (SVT). Although the majority of the respondents demonstrated technical knowledge about symptom validity, a sizeable minority of the respondents relied on outdated notions (e.g., the idea that clinicians can determine symptom credibility based on intuitive judgment). There is little consensus among neuropsychologists on how to instruct patients when they are administered SVTs and how to handle test failure. Our findings indicate that the issues regarding how to administer and communicate the SVT results to patients warrant systematic research. © The Author 2013. Published by Oxford University Press. All rights reserved.
AB - During the last decades, symptom validity has become an important topic in the neuropsychological and psychiatric literature with respect to howit relates to malingering, factitious disorder, and somatoform complaints.We conducted a surveyamongneuropsychologists (N = 515) from six European countries (Germany, Italy, Denmark, Finland, Norway, and the Netherlands).We queried the respondents about the tools they used to evaluate symptom credibility in clinical and forensic assessments and other issues related to symptom validity testing (SVT). Although the majority of the respondents demonstrated technical knowledge about symptom validity, a sizeable minority of the respondents relied on outdated notions (e.g., the idea that clinicians can determine symptom credibility based on intuitive judgment). There is little consensus among neuropsychologists on how to instruct patients when they are administered SVTs and how to handle test failure. Our findings indicate that the issues regarding how to administer and communicate the SVT results to patients warrant systematic research. © The Author 2013. Published by Oxford University Press. All rights reserved.
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84890246455&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/24047545
U2 - https://doi.org/10.1093/arclin/act073
DO - https://doi.org/10.1093/arclin/act073
M3 - Article
C2 - 24047545
SN - 1873-5843
VL - 28
SP - 771
EP - 783
JO - Archives of Clinical Neuropsychology
JF - Archives of Clinical Neuropsychology
IS - 8
ER -